Guidelines for heart transplantation

被引：30

作者：

de Jonge, N. ^{[1
]}

Kirkels, J. H. ^{[1
]}

Klopping, C. ^{[1
]}

Lahpor, J. R. ^{[1
]}

Caliskan, K. ^{[2
]}

Maat, A. P. W. M. ^{[2
]}

Brugemann, J. ^{[3
]}

Erasmus, M. E. ^{[3
]}

Klautz, R. J. M. ^{[4
]}

Verwey, H. F. ^{[4
]}

Oomen, A. ^{[5
]}

Peels, C. H. ^{[6
]}

Goluke, A. E. J. ^{[7
]}

Nicastia, D. M. ^{[8
]}

Koole, M. A. C. ^{[9
]}

Balk, A. H. M. M. ^{[2
]}

机构：

[1] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, NL-3508 GA Utrecht, Netherlands

[2] Erasmus Mc, Rotterdam, Netherlands

[3] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Antonius Hosp, Sneek, Netherlands

[6] Catharina Hosp, Eindhoven, Netherlands

[7] Zevenaar Hosp, Zevenaar, Netherlands

[8] Gelre Hosp, Apeldoorn, Netherlands

[9] Red Cross Hosp, Beverwijk, Netherlands

来源：

NETHERLANDS HEART JOURNAL | 2008年 / 16卷 / 03期

关键词：

heart transplantation; heart failure; guide-lines;

D O I：

10.1007/BF03086123

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Based on the changes in the field of heart transplantation and the treatment and prognosis of patients with heart failure, these updated guidelines were composed by a committee under the supervision of both the Netherlands Society of Cardiology and the Netherlands Association for Cardiothoracic surgery (NVVC and NVT). The indication for heart transplantation is defined as: 'End-stage heart disease not remediable by more conservative measures'. Contraindications are: irreversible pulmonary hypertension/elevated pulmonary vascular resistance; active systemic infection; active malignancy or history of malignancy with probability of recurrence; inability to comply with complex medical regimen; severe peripheral or cerebrovascular disease and irreversible dysfunction of another organ, including diseases that may limit prognosis after heart transplantation. Considering the difficulties in defining end-stage heart failure, estimating prognosis in the individual patient and the continuing evolution of available therapies, the present criteria are broadly defined. The final acceptance is done by the transplant team which has extensive knowledge of the treatment of patients with advanced heart failure on the one hand and thorough experience with heart transplantation and mechanical circulatory support on the other hand.

引用

页码：79 / 87

页数：9

共 43 条

[1] Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [J].

Aaronson, KD ;

Schwartz, JS ;

Chen, TM ;

Wong, KL ;

Goin, JE ;

Mancini, DM .

CIRCULATION, 1997, 95 (12) :2660-2667

[2]

BALK AHM, 1998, CARDIOLOGIE, V5, P702

[3] Selection of patients for heart transplantation in the current era of heart failure therapy [J].

Butler, J ;

Khadim, G ;

Paul, KM ;

Davis, SF ;

Kronenberg, MW ;

Chomsky, DB ;

Pierson, RN ;

Wilson, JR .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :787-793

[4] Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure [J].

Chua, TP ;

Ponikowski, P ;

Harrington, D ;

Anker, SD ;

WebbPeploe, K ;

Clark, AL ;

PooleWilson, PA ;

Coats, AJS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (07) :1585-1590

[5]

COPPEN R, 2003, DONORPOTENTIEEL VERG

[6]

de Jonge N, 2004, Neth Heart J, V12, P548

[7] Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation -: An outlook for permanent assisting? [J].

de Jonge, N ;

Kirkels, H ;

Lahpor, JR ;

Klöpping, C ;

Hulzebos, EJ ;

de la Rivière, AB ;

de Medina, EOR .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) :1794-1799

[8] Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation [J].

Dew, MA ;

Kormos, RL ;

Roth, LH ;

Murali, S ;

DiMartini, A ;

Griffith, BP .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (06) :549-562

[9]

DUPORT N, 2005, ORGANS TISSUE, V2, P93

[10]

ERICKSON KW, 1990, J HEART TRANSPLANT, V9, P526

← 1 2 3 4 5 →